[{"AccountsPayableCurrent_0_Q2_USD":6364.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-95136.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-616225.0,"NetIncomeLoss_1_Q2_USD":286223.0,"NetIncomeLoss_2_Q2_USD":-9149309.0,"NonoperatingIncomeExpense_1_Q2_USD":529891.0,"NonoperatingIncomeExpense_2_Q2_USD":-8411823.0,"OperatingIncomeLoss_1_Q2_USD":-243668.0,"OperatingIncomeLoss_2_Q2_USD":-737486.0,"OtherCostAndExpenseOperating_2_Q2_USD":329713.0,"OtherNonoperatingExpense_2_Q2_USD":317023.0,"OtherUnderwritingExpense_2_Q2_USD":2000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockSharesIssued_0_Q2_shares":null,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":31.0,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PrepaidExpenseCurrent_0_Q2_USD":79381.0,"PrepaidExpenseNoncurrent_0_Q2_USD":15397.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":52627.0,"ProfitLoss_1_Q2_USD":286223.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":147763.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-7729664.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0074,"SharePrice_0_Q2_USD":10.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q2_shares":7870157.0,"StockholdersEquity_0_Q2_USD":5000002.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":291330.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":78701570.0,"PreferredStockValue_0_Q2_USD":null,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":12.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":100031414.0,"MarketableSecurities_0_Q2_USD":100031414.0,"AdditionalPaidInCapital_0_Q2_USD":12729166.0,"Assets_0_Q2_USD":100509592.0,"AssetsCurrent_0_Q2_USD":462781.0,"AssetsHeldInTrust_0_Q2_USD":100031414.0,"AssetsHeldInTrustCurrent_0_Q2_USD":100031414.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0_Q2_USD":5000001.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":383400.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-711361.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"DeferredOfferingCosts_0_Q2_USD":329713.0,"DerivativeFairValueOfDerivativeNet_0_Q2_USD":14465458.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.06,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.02,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_2_Q2_USD":2000000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":-528317.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":8427107.0,"LiabilitiesCurrent_0_Q2_USD":219839.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":100509592.0,"Liabilities_0_Q2_USD":16808020.0,"InvestmentIncomeInterest_2_Q2_USD":15253.0,"InterestIncomeOther_2_Q2_USD":15253.0,"InterestIncomeOther_1_Q2_USD":1562.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":4984843.0,"IncreaseDecreaseInPropertyAndOtherTaxesPayable_2_Q2_USD":100000.0,"IncreaseDecreaseInDueToRelatedParties_2_Q2_USD":-34334.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1365.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":100016161.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q2_USD":3310.0,"HeldToMaturitySecurities_0_Q2_USD":100012851.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q2_USD":250000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-54199.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":4539131.0,"Ticker":"HUMA","CIK":"1818382","name":"ALPHA HEALTHCARE ACQUISITION CORP.","OfficialName":"Humacyte Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"762233833.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]